{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:38:57Z","timestamp":1793392737652,"version":"4.5.0"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Tremor is a common movement disorder. Essential tremor (ET) is the most common etiology of tremor, while hands tremor is the most disabling type of tremor. This study aimed to explore the effects of Botulinum toxin (BoNT) on tremor within 6 weeks of treatment, and the muscular weakness adverse effect within 6 weeks specifically in randomized controlled trials. PubMed, Embase, and Cochrane Library databases were searched. Tremor severity and grip strength after BoNT treatment were investigated. BoNT significantly attenuated hand tremor severity in patients with either essential tremor (ET), Parkinson\u2019s disease or multiple sclerosis (Standardized mean difference [SMD] = \u22120.59, 95% confidence interval [CI], \u22120.95 to \u22120.24, p = 0.001, I2 = 46%). Regarding people with ET, BoNT significantly reduced their tremor severity, including hands tremor and head tremor within 6 weeks of treatment (SMD = \u22120.58, 95% CI, \u22120.28 to \u22120.88, p = 0.002, I2 = 0%). Electromyography (EMG) but not anatomical guidance BoNT injection provided significant benefit on the relief of tremor in both conditions. The principal adverse event was weakness, but it did not worse within 6 weeks of BoNT treatment (SMD = \u22120.35, 95% CI, \u22120.83 to 0.12, p = 0.07, I2 = 57%), as assessed by the subjective grip strength. In conclusion, BoNT was an effective treatment for the hand tremor and ET, and EMG guidance injection was preferred. In addition, the muscular weakness adverse effect was not significant.<\/jats:p>","DOI":"10.3390\/toxins14030203","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T20:19:10Z","timestamp":1646943550000},"page":"203","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Botulinum Toxin for Essential Tremor and Hands Tremor in the Neurological Diseases: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0498-4695","authenticated-orcid":false,"given":"Yen-Hui","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Neurology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7448-1041","authenticated-orcid":false,"given":"Chien-Tai","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City 235, Taiwan"},{"name":"Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6722-1153","authenticated-orcid":false,"given":"Tsai-Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Nursing, College of Nursing, Taipei Medical University, Taipei 110, Taiwan"},{"name":"Cochrane Taiwan, Taipei Medical University, Taipei 110, Taiwan"},{"name":"Center for Nursing and Healthcare Research in Clinical Practice Application, Wan Fang Hospital, Taipei Medical University, Taipei 110, Taiwan"},{"name":"Department of Nursing, Wan Fang Hospital, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society","volume":"33","author":"Bhatia","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7326\/0003-4819-93-3-460","article-title":"Physiologic and Pathologic Tremors. Diagnosis, mechanism, and management","volume":"93","author":"Jankovic","year":"1980","journal-title":"Ann. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2008.10.006","article-title":"Embarrassment in essential tremor: Prevalence, clinical correlates and therapeutic implications","volume":"15","author":"Louis","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/CON.0000000000000748","article-title":"Tremor","volume":"25","author":"Louis","year":"2019","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00415-012-6628-x","article-title":"Treatment of essential tremor: A systematic review of evidence and recommendations from the Italian Movement Disorders Association","volume":"260","author":"Zappia","year":"2013","journal-title":"J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2174\/1570159X18666200124145743","article-title":"Current and Future Neuropharmacological Options for the Treatment of Essential Tremor","volume":"18","author":"Agundez","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","article-title":"Acute and chronic effects of propranolol and primidone in essential tremor","volume":"39","author":"Koller","year":"1989","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/mds.10083","article-title":"Randomized trial comparing primidone initiation schedules for treating essential tremor","volume":"17","author":"Dewey","year":"2002","journal-title":"Mov. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s00415-018-8823-x","article-title":"Deep brain stimulation in uncommon tremor disorders: Indications, targets, and programming","volume":"265","author":"Artusi","year":"2018","journal-title":"J. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/mds.23195","article-title":"Deep brain stimulation for essential tremor: A systematic review","volume":"25","author":"Perera","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.parkreldis.2020.06.008","article-title":"Motor outcomes and adverse effects of deep brain stimulation for dystonic tremor: A systematic review","volume":"76","author":"Tsuboi","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.parkreldis.2018.08.017","article-title":"STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: A systematic review and meta-analysis","volume":"58","author":"Wong","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1002\/mds.20958","article-title":"Anatomy and physiology of the basal ganglia: Implications for deep brain stimulation for Parkinson\u2019s disease","volume":"21","author":"Kopell","year":"2006","journal-title":"Mov. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jnnp-2018-318240","article-title":"Outcomes from stereotactic surgery for essential tremor","volume":"90","author":"Dallapiazza","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.3949\/ccjm.79.s2a.04","article-title":"Deep brain stimulation for movement disorders: Patient selection and technical options","volume":"79","author":"Fernandez","year":"2012","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nurt.2007.10.072","article-title":"The treatment of movement disorders by deep brain stimulation","volume":"5","author":"Yu","year":"2008","journal-title":"Neurotherapeutics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1056\/NEJMoa1600159","article-title":"A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor","volume":"375","author":"Elias","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_18","unstructured":"Health Quality Ontario (2018). Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment. Ont. Health Technol. Assess. Ser., 18, 1\u2013141."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.27072","article-title":"Botulinum toxin: State of the art","volume":"32","author":"Jankovic","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/toxins5020249","article-title":"Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia","volume":"5","author":"Jankovic","year":"2013","journal-title":"Toxins"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.toxicon.2014.07.009","article-title":"Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: A 20-year follow-up","volume":"90","author":"Jankovic","year":"2014","journal-title":"Toxicon"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"l4485","DOI":"10.1136\/bmj.l4485","article-title":"Essential tremor: Diagnosis and management","volume":"366","author":"Shanker","year":"2019","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"101984","DOI":"10.1016\/j.msard.2020.101984","article-title":"OnabotulinumtoxinA treatment for MS-tremor modifies fMRI tremor response in central sensory-motor integration areas","volume":"40","author":"Boonstra","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin","year":"2001","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov. Disord."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Jog, M., Lee, J., Scheschonka, A., Chen, R., Ismail, F., Boulias, C., Hobson, D., King, D., Althaus, M., and Simon, O. (2020). Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-blind, Placebo-Controlled Study. Toxins, 12.","DOI":"10.3390\/toxins12120807"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.mayocp.2017.06.010","article-title":"Botulinum Toxin in Parkinson Disease Tremor: A Randomized, Double-Blind, Placebo-Controlled Study with a Customized Injection Approach","volume":"92","author":"Mittal","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parkreldis.2018.06.019","article-title":"Botulinum toxin in essential hand tremor\u2014A randomized double-blind placebo-controlled study with customized injection approach","volume":"56","author":"Mittal","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.45.4.822","article-title":"Botulinum toxin treatment of essential head tremor","volume":"45","author":"Pahwa","year":"1995","journal-title":"Neurology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1212\/WNL.0b013e31825dcdd9","article-title":"A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor","volume":"79","author":"Sung","year":"2012","journal-title":"Neurology"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Anandan, C., and Jankovic, J. (2021). Botulinum Toxin in Movement Disorders: An Update. Toxins, 13.","DOI":"10.3390\/toxins13010042"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199104253241707","article-title":"Therapeutic Uses of Botulinum Toxin","volume":"324","author":"Oates","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2019.01.023","article-title":"Botulinum toxin for the treatment of tremor","volume":"63","author":"Mittal","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxicon.2020.02.020","article-title":"Clinical duration of action of different botulinum toxin types in humans","volume":"179","author":"Eleopra","year":"2020","journal-title":"Toxicon"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.toxicon.2017.10.027","article-title":"Direct central nervous system effects of botulinum neurotoxin","volume":"147","author":"Caleo","year":"2018","journal-title":"Toxicon"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/archneur.61.9.1416","article-title":"Botulinum Toxin Type A for Treating Voice Tremor","volume":"61","author":"Adler","year":"2004","journal-title":"Arch. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jocn.2012.12.025","article-title":"Safety and efficacy of botulinum toxin in primary orthostatic tremor","volume":"20","author":"Bertram","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mdc3.12832","article-title":"Treatment of Upper Limb Tremor with Botulinum Toxin: An Individualized Approach","volume":"6","author":"Kamel","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/1468-0009.12210","article-title":"The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta-analyses","volume":"94","author":"Ioannidis","year":"2016","journal-title":"Milbank Q."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/14\/3\/203\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:34:10Z","timestamp":1760135650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/14\/3\/203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["toxins14030203"],"URL":"https:\/\/doi.org\/10.3390\/toxins14030203","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]}}}